We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$33.6B
AUM Growth
+$255M
Cap. Flow
-$824M
Cap. Flow %
-2.45%
Top 10 Hldgs %
29.14%
Holding
1,152
New
97
Increased
418
Reduced
387
Closed
96

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$94.4M
2
ELV icon
Elevance Health
ELV
+$74.7M
3
PAYO icon
Payoneer
PAYO
+$71.5M
4
ABT icon
Abbott
ABT
+$64.2M
5
GE icon
GE Aerospace
GE
+$63.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$101M
2
AAPL icon
Apple
AAPL
+$98.8M
3
AMGN icon
Amgen
AMGN
+$85.8M
4
TXN icon
Texas Instruments
TXN
+$80.9M
5
BIIB icon
Biogen
BIIB
+$73M

Sector Composition

Rank Sector Weight
1 Technology 37.8%
2 Healthcare 15.65%
3 Consumer Discretionary 11.06%
4 Financials 8.19%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
426
Ingersoll Rand
IR
$33.1B
$7.98M 0.02%
87,829
+39,417
+81% +$3.62M
R icon
427
Ryder
R
$9.9B
$7.94M 0.02%
64,116
PSX icon
428
Phillips 66
PSX
$82.9B
$7.94M 0.02%
56,263
-19,317
-26% -$2.86M
RDN icon
429
Radian Group
RDN
$5.28B
$7.91M 0.02%
254,422
EIX icon
430
Edison International
EIX
$30.3B
$7.79M 0.02%
108,429
+27,671
+34% +$2.01M
ALSN icon
431
Allison Transmission
ALSN
$9.51B
$7.73M 0.02%
101,847
+11,914
+13% +$913K
DASH icon
432
DoorDash
DASH
$84.3B
$7.71M 0.02%
70,885
-36,288
-34% -$4.37M
CUBE icon
433
CubeSmart
CUBE
$9.61B
$7.68M 0.02%
169,936
ONC
434
BeOne Medicines Ltd
ONC
$33.9B
$7.63M 0.02%
53,498
+31
+0.1% +$4.78K
CCI icon
435
Crown Castle
CCI
$34.6B
$7.61M 0.02%
77,912
+23,124
+42% +$2.28M
BNTX icon
436
BioNTech
BNTX
$23.5B
$7.58M 0.02%
94,273
-74,713
-44% -$6.83M
DEA
437
Easterly Government Properties
DEA
$1.16B
$7.56M 0.02%
244,431
WK icon
438
Workiva
WK
$3.45B
$7.51M 0.02%
102,832
-3,007
-3% -$237K
IFF icon
439
International Flavors & Fragrances
IFF
$20.3B
$7.5M 0.02%
+78,766
New +$7.22M
FDS icon
440
Factset
FDS
$10B
$7.5M 0.02%
18,361
+10,903
+146% +$4.63M
MGM icon
441
MGM Resorts International
MGM
$11.7B
$7.5M 0.02%
168,673
-139,135
-45% -$5.82M
NTRS icon
442
Northern Trust
NTRS
$21.8B
$7.48M 0.02%
89,101
+45,253
+103% +$3.8M
DBX icon
443
Dropbox
DBX
$7.78B
$7.43M 0.02%
330,504
+237,135
+254% +$5.42M
DYN icon
444
Dyne Therapeutics
DYN
$4.68B
$7.42M 0.02%
210,149
-68,417
-25% -$1.99M
TCOM icon
445
Trip.com Group
TCOM
$29B
$7.38M 0.02%
157,009
+23,819
+18% +$1.21M
BRO icon
446
Brown & Brown
BRO
$25.1B
$7.34M 0.02%
82,100
-13,100
-14% -$1.14M
XENE icon
447
Xenon Pharmaceuticals
XENE
$6.1B
$7.33M 0.02%
188,038
+166
+0.1% +$6.64K
KMI icon
448
Kinder Morgan
KMI
$70.9B
$7.29M 0.02%
366,951
-89,961
-20% -$1.72M
EPC icon
449
Edgewell Personal Care
EPC
$1.3B
$7.25M 0.02%
180,275
-339
-0.2% -$13K
BR icon
450
Broadridge
BR
$18.4B
$7.18M 0.02%
36,432
+737
+2% +$146K

Similar funds

Axa's Q2 2024 Portfolio in Review

As of Q2 2024, Axa held 1,152 positions worth $33.6B, up 0.76% from $33.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Axa's Q2 2024 filing shows 97 new, 418 increased, 387 reduced and 96 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M. The largest sale was UnitedHealth, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M.
  • Axa added most to Advanced Micro Devices in Q2 2024, an estimated $94.4M increase.
  • Axa's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $101M.
  • Axa fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Axa's ten largest holdings make up 29% of its $33.6B portfolio in Q2 2024.
  • Axa opened 97 new positions and closed 96 in Q2 2024.
  • Axa's portfolio value rose 0.76% quarter-over-quarter to $33.6B.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.